Literature DB >> 31777936

Imaging biomarkers for brain metastases: more than meets the eye.

Sanjay Aneja1,2, Antonio Omuro1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31777936      PMCID： PMC6917408          DOI： 10.1093/neuonc/noz193

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  9 in total

1.  Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.

Authors:  Hie Bum Suh; Yoon Seong Choi; Sohi Bae; Sung Soo Ahn; Jong Hee Chang; Seok-Gu Kang; Eui Hyun Kim; Se Hoon Kim; Seung-Koo Lee
Journal:  Eur Radiol       Date:  2018-04-06       Impact factor: 5.315

2.  The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository.

Authors:  Kenneth Clark; Bruce Vendt; Kirk Smith; John Freymann; Justin Kirby; Paul Koppel; Stephen Moore; Stanley Phillips; David Maffitt; Michael Pringle; Lawrence Tarbox; Fred Prior
Journal:  J Digit Imaging       Date:  2013-12       Impact factor: 4.056

Review 3.  Advances in therapy for melanoma brain metastases.

Authors:  Jaclyn C Flanigan; Lucia B Jilaveanu; Veronica L Chiang; Harriet M Kluger
Journal:  Clin Dermatol       Date:  2013 May-Jun       Impact factor: 3.541

4.  Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.

Authors:  Sarah B Goldberg; Scott N Gettinger; Amit Mahajan; Anne C Chiang; Roy S Herbst; Mario Sznol; Apostolos John Tsiouris; Justine Cohen; Alexander Vortmeyer; Lucia Jilaveanu; James Yu; Upendra Hegde; Stephanie Speaker; Matthew Madura; Amanda Ralabate; Angel Rivera; Elin Rowen; Heather Gerrish; Xiaopan Yao; Veronica Chiang; Harriet M Kluger
Journal:  Lancet Oncol       Date:  2016-06-03       Impact factor: 41.316

5.  MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors.

Authors:  Ankush Bhatia; Maxwell Birger; Harini Veeraraghavan; Hyemin Um; Florent Tixier; Anna Sophia McKenney; Marina Cugliari; Annalise Caviasco; Angelica Bialczak; Rachna Malani; Jessica Flynn; Zhigang Zhang; T Jonathan Yang; Bianca D Santomasso; Alexander N Shoushtari; Robert J Young
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

6.  Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging.

Authors:  Ken Chang; Harrison X Bai; Hao Zhou; Chang Su; Wenya Linda Bi; Ena Agbodza; Vasileios K Kavouridis; Joeky T Senders; Alessandro Boaro; Andrew Beers; Biqi Zhang; Alexandra Capellini; Weihua Liao; Qin Shen; Xuejun Li; Bo Xiao; Jane Cryan; Shakti Ramkissoon; Lori Ramkissoon; Keith Ligon; Patrick Y Wen; Ranjit S Bindra; John Woo; Omar Arnaout; Elizabeth R Gerstner; Paul J Zhang; Bruce R Rosen; Li Yang; Raymond Y Huang; Jayashree Kalpathy-Cramer
Journal:  Clin Cancer Res       Date:  2017-11-22       Impact factor: 13.801

7.  Preoperative MRI-radiomics features improve prediction of survival in glioblastoma patients over MGMT methylation status alone.

Authors:  Florent Tixier; Hyemin Um; Dalton Bermudez; Aditi Iyer; Aditya Apte; Maya S Graham; Kathryn S Nevel; Joseph O Deasy; Robert J Young; Harini Veeraraghavan
Journal:  Oncotarget       Date:  2019-01-18

8.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

9.  Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer.

Authors:  A S Mansfield; M C Aubry; J C Moser; S M Harrington; R S Dronca; S S Park; H Dong
Journal:  Ann Oncol       Date:  2016-08-08       Impact factor: 32.976
  9 in total
  1 in total

Review 1.  Brain metastases: the role of clinical imaging.

Authors:  Sophie H A E Derks; Astrid A M van der Veldt; Marion Smits
Journal:  Br J Radiol       Date:  2021-12-14       Impact factor: 3.039
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.